Gene Therapy
CytoGenix and USAMRIID to Collaborate in Developing Biodefense synDNA Vaccines
Published in Gene Therapy Weekly, April 12th, 2007
Scientists from CytoGenix and USAMRIID, led by Dr. Connie Schmaljohn, intend to develop and test synDNA(TM) vaccines for the prevention of disease caused by the Ebola virus and several strains of equine encephalitis viruses.
Dr. Malcolm Skolnick, CytoGenix Chief Executive Officer, stated, "We are pleased to have the opportunity to work with Dr. Schmaljohn and the USAMRIID team at Fort Detrick. These disease targets are listed as Category A & B...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-04-12)
More Articles from Gene Therapy Weekly
- Gene Therapy
Molecular tools make the cut - Cancer Vaccines
Vical Announces Licensee's Conditional Approval of Therapeutic Cancer Vaccine for Dogs - Gene Therapy
HBIO Announces Strategic Alliance With Nanoentek - Gene Therapy
Secret Process Lets Questionable Grant Slip By Stem Cell Committee; Investigate Grantee Before $2.6 million Payout, Consumer Advocates Say - Cancer Gene Therapy
Data from University of Tokyo, Institute of Medical Science advance knowledge in cancer gene therapy - Cancer Gene Therapy
Data on cancer gene therapy described by researchers at University of Texas, M. D. Anderson Cancer Center - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
